Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.68 - $2.19 $26,450 - $85,186
38,898 Added 145.02%
65,720 $62,000
Q4 2022

Feb 14, 2023

BUY
$0.55 - $0.85 $14,752 - $22,798
26,822 New
26,822 $16,000
Q2 2022

Aug 05, 2022

BUY
$1.05 - $5.35 $32,690 - $166,566
31,134 New
31,134 $36,000

About Addex Therapeutics Ltd.


  • Ticker ADXN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,204,630
  • Market Cap $62.4M
  • Description
  • Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...
More about ADXN
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.